630 related articles for article (PubMed ID: 15648083)
1. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.
Nilsson B; Bümming P; Meis-Kindblom JM; Odén A; Dortok A; Gustavsson B; Sablinska K; Kindblom LG
Cancer; 2005 Feb; 103(4):821-9. PubMed ID: 15648083
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
3. Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea.
Kang YK; Kim KM; Sohn T; Choi D; Kang HJ; Ryu MH; Kim WH; Yang HK;
J Korean Med Sci; 2010 Nov; 25(11):1543-52. PubMed ID: 21060741
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Ki67 index in gastrointestinal stromal tumors.
Zhao WY; Xu J; Wang M; Zhang ZZ; Tu L; Wang CJ; Lin TL; Shen YY; Liu Q; Cao H
Int J Clin Exp Pathol; 2014; 7(5):2298-304. PubMed ID: 24966939
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group.
Abdalla TSA; Pieper L; Kist M; Thomaschewski M; Klinkhammer-Schalke M; Zeissig SR; Tol KK; Wellner UF; Keck T; Hummel R
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7461-7469. PubMed ID: 36959341
[TBL] [Abstract][Full Text] [Related]
6. Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.
Koo DH; Ryu MH; Kim KM; Yang HK; Sawaki A; Hirota S; Zheng J; Zhang B; Tzen CY; Yeh CN; Nishida T; Shen L; Chen LT; Kang YK
Cancer Res Treat; 2016 Oct; 48(4):1155-1166. PubMed ID: 27384163
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors.
Sun M; Tong Y; Yuan W; Wang Y; Pu Y; Huang W; Lv B; Xu C; Jiang W; Luo R; Fang R; Tang S; Ren L; Wang J; Feng J; Sun C; Shen K; He F; Hou Y; Ding C
Gastroenterology; 2024 Mar; 166(3):450-465.e33. PubMed ID: 37995868
[TBL] [Abstract][Full Text] [Related]
8. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies.
Søreide K; Sandvik OM; Søreide JA; Giljaca V; Jureckova A; Bulusu VR
Cancer Epidemiol; 2016 Feb; 40():39-46. PubMed ID: 26618334
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
Hirota S; Isozaki K; Moriyama Y; Hashimoto K; Nishida T; Ishiguro S; Kawano K; Hanada M; Kurata A; Takeda M; Muhammad Tunio G; Matsuzawa Y; Kanakura Y; Shinomura Y; Kitamura Y
Science; 1998 Jan; 279(5350):577-80. PubMed ID: 9438854
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors: pathology and prognosis at different sites.
Miettinen M; Lasota J
Semin Diagn Pathol; 2006 May; 23(2):70-83. PubMed ID: 17193820
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000.
Tran T; Davila JA; El-Serag HB
Am J Gastroenterol; 2005 Jan; 100(1):162-8. PubMed ID: 15654796
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.
Tryggvason G; Gíslason HG; Magnússon MK; Jónasson JG
Int J Cancer; 2005 Nov; 117(2):289-93. PubMed ID: 15900576
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors: epidemiology, clinical picture, diagnosis, prognosis and treatment.
Cichoz-Lach H; Kasztelan-Szczerbińska B; Słomka M
Pol Arch Med Wewn; 2008 Apr; 118(4):216-21. PubMed ID: 18575421
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Dematteo RP; Ballman KV; Antonescu CR; Maki RG; Pisters PW; Demetri GD; Blackstein ME; Blanke CD; von Mehren M; Brennan MF; Patel S; McCarter MD; Polikoff JA; Tan BR; Owzar K;
Lancet; 2009 Mar; 373(9669):1097-104. PubMed ID: 19303137
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD; Reichardt P; Kang YK; Blay JY; Rutkowski P; Gelderblom H; Hohenberger P; Leahy M; von Mehren M; Joensuu H; Badalamenti G; Blackstein M; Le Cesne A; Schöffski P; Maki RG; Bauer S; Nguyen BB; Xu J; Nishida T; Chung J; Kappeler C; Kuss I; Laurent D; Casali PG;
Lancet; 2013 Jan; 381(9863):295-302. PubMed ID: 23177515
[TBL] [Abstract][Full Text] [Related]
17. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
[TBL] [Abstract][Full Text] [Related]
18. Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study.
Goettsch WG; Bos SD; Breekveldt-Postma N; Casparie M; Herings RM; Hogendoorn PC
Eur J Cancer; 2005 Dec; 41(18):2868-72. PubMed ID: 16293410
[TBL] [Abstract][Full Text] [Related]
19. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
[TBL] [Abstract][Full Text] [Related]
20. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
Demetri GD; Benjamin RS; Blanke CD; Blay JY; Casali P; Choi H; Corless CL; Debiec-Rychter M; DeMatteo RP; Ettinger DS; Fisher GA; Fletcher CD; Gronchi A; Hohenberger P; Hughes M; Joensuu H; Judson I; Le Cesne A; Maki RG; Morse M; Pappo AS; Pisters PW; Raut CP; Reichardt P; Tyler DS; Van den Abbeele AD; von Mehren M; Wayne JD; Zalcberg J;
J Natl Compr Canc Netw; 2007 Jul; 5 Suppl 2():S1-29; quiz S30. PubMed ID: 17624289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
